Market Cap 1.15B
Revenue (ttm) 0.00
Net Income (ttm) -244.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,239,900
Avg Vol 2,746,526
Day's Range N/A - N/A
Shares Out 299.36M
Stochastic %K 26%
Beta 2.12
Analysts Strong Sell
Price Target $9.38

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 701 7914
Address:
188 East Blaine Street, Suite 400, Seattle, United States
BBraggHillBoys
BBraggHillBoys Sep. 5 at 4:33 PM
$SANA market has moved past MAYO; onto investor conferences.
0 · Reply
Inflames_swe
Inflames_swe Sep. 4 at 7:43 PM
$SANA cheers mates. Any news regarding mayo?
1 · Reply
CapitalMonk
CapitalMonk Sep. 4 at 7:22 PM
$SANA Price: $3.87 (-1.40%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±2.55% RSI: 54.5 | Momentum: Moderate Volume: -66.6% vs avg Volatility: 4.78% Support: $3.37 | Resistance: $4.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
BriOnH
BriOnH Sep. 4 at 5:32 PM
$SANA $ELDN $DXCM $PODD $TNDM Today is scheduled to be the first person ever dosed with Endo Axium Smart Oral Insulin. This could potentially radically change the lives for us T1D's, with even better stuff on the horizon. 🙏🏻🤞
2 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 4 at 1:46 PM
$RXRX AI in Biology 🚀 Bio 💎 s $AMLX $75 $SMMT $40 $SANA $10 plus 🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 4 at 1:35 PM
$RXRX Good Morning ☕️ $SANA $AMLX $PRME
0 · Reply
CapitalMonk
CapitalMonk Sep. 3 at 5:36 PM
$SANA Price: $3.89 (+0.13%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±3.16% RSI: 55.1 | Momentum: Moderate Volume: -68.8% vs avg Volatility: 4.92% Support: $3.37 | Resistance: $4.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
CapitalMonk
CapitalMonk Sep. 2 at 6:47 PM
$SANA Price: $3.90 (+1.96%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±4.10% RSI: 52.9 | Momentum: Moderate Volume: -43.5% vs avg Volatility: 4.96% Support: $3.35 | Resistance: $4.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
BriOnH
BriOnH Sep. 2 at 4:38 PM
$SANA I am not feeling very bullish with no Mayo news but the chart is feeling very bullish. Such a pretty setup. Have a Cup and Handle (again) potentially leading to a breakout. Need to push above critical resistance (red line) 4.09, and hopefully just blast through. <=3.52 is the stop. No trades open for me right now in Sana, but considering it. Obviously have my investment position ive been acquiring over the past however many years its been now, that doesn't get any shares sold until I get sc451, or God forbid some unforeseen craziness in trials.
2 · Reply
mirko_papuga
mirko_papuga Sep. 2 at 3:16 PM
$SANA Bought 400 shares at $3.82 this morning. Hanging in until the Investor Calls next week. Good luck to everyone!
1 · Reply
Latest News on SANA
Sana Biotechnology price target lowered to $6 from $7 at BofA

2026-08-16T13:45:39.000Z - 21 days ago

Sana Biotechnology price target lowered to $6 from $7 at BofA


Sana Biotechnology reports Q2 EPS (13c), consensus (12c)

2026-08-10T20:46:01.000Z - 27 days ago

Sana Biotechnology reports Q2 EPS (13c), consensus (12c)


Sana Biotechnology Earnings release: Q2 2026

Aug 10, 2026, 4:00 PM EDT - 27 days ago

Sana Biotechnology Earnings release: Q2 2026


Sana Biotechnology Quarterly report: Q2 2026

Aug 10, 2026, 4:00 PM EDT - 27 days ago

Sana Biotechnology Quarterly report: Q2 2026


Sana Biotechnology Slides: Corporate presentation

Aug 10, 2026, 7:00 AM EDT - 27 days ago

Sana Biotechnology Slides: Corporate presentation


Sana Biotechnology to Present at June 2026 Investor Conferences

May 27, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology to Present at June 2026 Investor Conferences


Sana Biotechnology Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Earnings release: Q1 2026


Sana Biotechnology Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Quarterly report: Q1 2026


Sana Biotechnology Slides: Corporate presentation

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Slides: Corporate presentation


Sana Biotechnology initiated with a Buy at Rodman & Renshaw

2026-05-11T17:02:47.000Z - 3 months ago

Sana Biotechnology initiated with a Buy at Rodman & Renshaw


Sana Biotechnology Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sana Biotechnology Proxy statement: Proxy filing


Sana Biotechnology Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sana Biotechnology Proxy statement: Proxy filing


Sana Biotechnology price target raised to $7 from $6 at Wedbush

2026-04-14T13:23:10.000Z - 4 months ago

Sana Biotechnology price target raised to $7 from $6 at Wedbush


Sana Biotechnology Slides: Corporate presentation

Apr 13, 2026, 7:00 AM EDT - 4 months ago

Sana Biotechnology Slides: Corporate presentation


Sana Biotechnology files automatic mixed securities shelf

2026-03-03T22:25:38.000Z - 6 months ago

Sana Biotechnology files automatic mixed securities shelf


Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

2026-03-03T21:25:24.000Z - 6 months ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)


Sana Biotechnology Annual report: Q4 2025

Mar 3, 2026, 3:00 PM EST - 6 months ago

Sana Biotechnology Annual report: Q4 2025


Sana Biotechnology Earnings release: Q4 2025

Mar 3, 2026, 3:00 PM EST - 6 months ago

Sana Biotechnology Earnings release: Q4 2025


Sana Biotechnology to Present at March 2026 Investor Conferences

Feb 23, 2026, 4:05 PM EST - 6 months ago

Sana Biotechnology to Present at March 2026 Investor Conferences


Sana Biotechnology appoints Piper as EVP, CFO

2026-02-17T14:16:15.000Z - 6 months ago

Sana Biotechnology appoints Piper as EVP, CFO


Sana Biotechnology Slides: Corporate presentation

Jan 14, 2026, 12:00 PM EST - 7 months ago

Sana Biotechnology Slides: Corporate presentation


Sana Biotechnology price target raised to $7 from $6 at BofA

2026-01-06T15:25:24.000Z - 8 months ago

Sana Biotechnology price target raised to $7 from $6 at BofA


Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

2025-11-06T23:25:54.000Z - 10 months ago

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)


Sana Biotechnology Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 10 months ago

Sana Biotechnology Earnings release: Q3 2025


Sana Biotechnology Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 10 months ago

Sana Biotechnology Quarterly report: Q3 2025


Sana Biotechnology Slides: Investor Presentation

Nov 5, 2025, 6:00 PM EST - 10 months ago

Sana Biotechnology Slides: Investor Presentation


Sana Biotechnology strength attributed to EMJ Capital long call

2025-10-15T17:45:20.000Z - 10 months ago

Sana Biotechnology strength attributed to EMJ Capital long call


Sana Biotechnology Quarterly report: Q2 2025

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Quarterly report: Q2 2025


Sana Biotechnology Earnings release: Q2 2025

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q2 2025


Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 11:24 PM EDT - 1 year ago

Sana Biotechnology Announces Pricing of Public Offering


Sana Biotechnology Slides: Corporate Presentation

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Sana Biotechnology Slides: Corporate Presentation


BBraggHillBoys
BBraggHillBoys Sep. 5 at 4:33 PM
$SANA market has moved past MAYO; onto investor conferences.
0 · Reply
Inflames_swe
Inflames_swe Sep. 4 at 7:43 PM
$SANA cheers mates. Any news regarding mayo?
1 · Reply
CapitalMonk
CapitalMonk Sep. 4 at 7:22 PM
$SANA Price: $3.87 (-1.40%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±2.55% RSI: 54.5 | Momentum: Moderate Volume: -66.6% vs avg Volatility: 4.78% Support: $3.37 | Resistance: $4.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
BriOnH
BriOnH Sep. 4 at 5:32 PM
$SANA $ELDN $DXCM $PODD $TNDM Today is scheduled to be the first person ever dosed with Endo Axium Smart Oral Insulin. This could potentially radically change the lives for us T1D's, with even better stuff on the horizon. 🙏🏻🤞
2 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 4 at 1:46 PM
$RXRX AI in Biology 🚀 Bio 💎 s $AMLX $75 $SMMT $40 $SANA $10 plus 🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 4 at 1:35 PM
$RXRX Good Morning ☕️ $SANA $AMLX $PRME
0 · Reply
CapitalMonk
CapitalMonk Sep. 3 at 5:36 PM
$SANA Price: $3.89 (+0.13%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±3.16% RSI: 55.1 | Momentum: Moderate Volume: -68.8% vs avg Volatility: 4.92% Support: $3.37 | Resistance: $4.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
CapitalMonk
CapitalMonk Sep. 2 at 6:47 PM
$SANA Price: $3.90 (+1.96%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±4.10% RSI: 52.9 | Momentum: Moderate Volume: -43.5% vs avg Volatility: 4.96% Support: $3.35 | Resistance: $4.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
BriOnH
BriOnH Sep. 2 at 4:38 PM
$SANA I am not feeling very bullish with no Mayo news but the chart is feeling very bullish. Such a pretty setup. Have a Cup and Handle (again) potentially leading to a breakout. Need to push above critical resistance (red line) 4.09, and hopefully just blast through. <=3.52 is the stop. No trades open for me right now in Sana, but considering it. Obviously have my investment position ive been acquiring over the past however many years its been now, that doesn't get any shares sold until I get sc451, or God forbid some unforeseen craziness in trials.
2 · Reply
mirko_papuga
mirko_papuga Sep. 2 at 3:16 PM
$SANA Bought 400 shares at $3.82 this morning. Hanging in until the Investor Calls next week. Good luck to everyone!
1 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 2 at 1:33 PM
$AMLX Good Morning my Bio 💎s ☕️$SMMT $RXRX $SANA
0 · Reply
JerryMalone32
JerryMalone32 Sep. 1 at 8:22 PM
$SANA conferences!
1 · Reply
CapitalMonk
CapitalMonk Sep. 1 at 7:38 PM
$SANA Price: $3.83 (-1.03%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±5.29% RSI: 50.9 | Momentum: Moderate Volume: -49.7% vs avg Volatility: 5.14% Support: $3.24 | Resistance: $4.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
BriOnH
BriOnH Sep. 1 at 4:47 PM
$SANA IF Mayo elected they have 10-20 days to close. Sec "3.2 Second Closing" in https://www.sec.gov/Archives/edgar/data/1770121/000119312526152868/sana-ex10_1.htm But also fear this could've been fair warning from the Aug 10q:"As of the filing of this Quarterly Report, Mayo Clinic has not elected to purchase the Additional Shares." While it isn't the end of the world, or sc451, if Mayo didn't agree to the 2nd tranche, it is in my _opinion_ a very red flag, and if I had to guess it's something around ph 1/2 scheduling. Time will tell what's happening or what happened with Mayo and the second tranche. Anyone else feeling a little disappointed here too as of right now?
2 · Reply
JerryMalone32
JerryMalone32 Sep. 1 at 12:37 AM
In past years, $SANA has done investor conferences with brokerage houses the week after labor day. Maybe they will announce something this week for that?
1 · Reply
CapitalMonk
CapitalMonk Aug. 31 at 10:19 PM
$SANA Price: $3.87 (-5.38%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±0.57% RSI: 55.4 | Momentum: Moderate Volume: -12.4% vs avg Volatility: 5.12% Support: $3.05 | Resistance: $4.22 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
JerryMalone32
JerryMalone32 Aug. 31 at 4:25 PM
Companies have 4 business days to file a form 8-K from the date of the material event so if Mayo opts in I would think an SEC filing by $SANA would be from today thru Friday.
1 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 31 at 3:38 PM
$RXRX Good Morning ☕️ Keep adding I guess. $ARBE $VIVO $SANA
0 · Reply
OnlyInvestor
OnlyInvestor Aug. 31 at 2:01 PM
Interest rate speculation is taking a fat 💩 on my small caps this month, even the ones with decent debt structure 😭😭😭 $IWM $SPIR $SANA $AMPG
0 · Reply
Boxcar66
Boxcar66 Aug. 31 at 11:46 AM
0 · Reply
JerryMalone32
JerryMalone32 Aug. 31 at 6:15 AM
$SANA look at this back-and-forth between Bob Nelsen of ARCH Ventures, a co-founder of Sana and Adam Feuerstein, a snarky (but smart) biotech journalist. It is sorta intense. LFG.
1 · Reply
JerryMalone32
JerryMalone32 Aug. 30 at 8:44 PM
$SANA food for thought. If mayo can do 50,000 procedures and charge just 10,000 for each that’s 500 million PER YEAR. IF Mayo buys another 7.5 million shares and Sana stock goes to $100, that’s 750 million. Just illustrating that really really big money can be made through being the partner of Sana on the clinic side. Yes, the investment in Sana stock is nothing to sneeze at. But the bigger return is in the procedures
0 · Reply